Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

References

• SalmonWDJrDaughadayWHA hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitroJ Lab Clin Med195749682583613429201
   PubMed Web of Science ®Google Scholar
• BaxterRCInsulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivitiesAm J Physiol Endocrinol Metab20002786E967E97610826997
   PubMed Web of Science ®Google Scholar
• ClemmonsDRUse of mutagenesis to probe IGF-binding protein structure/function relationshipsEndocr Rev200122680081711739334
   PubMed Web of Science ®Google Scholar
• KosteckaYBlahovecJInsulin-like growth factor binding proteins and their functions (minireview)Endocr Regul1999332909410467430
   PubMedGoogle Scholar
• LeRoithDWernerHBeitner-JohnsonDRobertsCTJrMolecular and cellular aspects of the insulin-like growth factor I receptorEndocr Rev19951621431637540132
   PubMed Web of Science ®Google Scholar
• MurphyLJInsulin-like growth factor-binding proteins: functional diversity or redundancy?J Mol Endocrinol1998212971079801453
   PubMed Web of Science ®Google Scholar
• SamaniAAYakarSLeRoithDBrodtPThe role of the IGF system in cancer growth and metastasis: overview and recent insightsEndocr Rev2007281204716931767
   PubMed Web of Science ®Google Scholar
• SridharSSGoodwinPJInsulin-insulin-like growth factor axis and colon cancerJ Clin Oncol200927216516719064959
   PubMed Web of Science ®Google Scholar
• ZarrilliRBruniCBRiccioAMultiple levels of control of insulin-like growth factor gene expressionMol Cell Endocrinol19941011–2R1R149397969
   PubMed Web of Science ®Google Scholar
• DaughadayWHThe possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumorsEndocrinology19901271142163304
   PubMed Web of Science ®Google Scholar
• MakiRGSmall is beautiful: insulin-like growth factors and their role in growth, development, and cancerJ Clin Oncol201028334985499520975071
   PubMed Web of Science ®Google Scholar
• MasoodiMAghazadehRSomiMHShavakhiHShabestariAAZaliMRSerum insulin-like growth factor-I and tumor size in patients with metastatic liver cancerHepat Mon200883179183
   Web of Science ®Google Scholar
• LeRoithDRobertsCTThe insulin-like growth factor system and cancerCancer Lett2003195212713712767520
   PubMed Web of Science ®Google Scholar
• RosenbloomALGuevara-AguirreJRosenfeldRGPollockBHGrowth in growth hormone insensitivityTrends Endocrinol Metab19945729630318407222
   PubMed Web of Science ®Google Scholar
• SmithRGJiangHSunYDevelopments in ghrelin biology and potential clinical relevanceTrends Endocrinol Metab200516943644216213742
   PubMed Web of Science ®Google Scholar
• VajdosFFUltschMSchafferMLCrystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactionsBiochemistry20014037110221102911551198
   PubMed Web of Science ®Google Scholar
• OhlssonCMohanSSjögrenKThe role of liver-derived insulin-like growth factor-IEndocr Rev200930549453519589948
   PubMed Web of Science ®Google Scholar
• FroeschERSchmidCSchwanderJZapfJActions of insulin-like growth factorsAnnu Rev Phsiol198547443467
   PubMed Web of Science ®Google Scholar
• SjögrenKLiuJLBladKLiver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in miceProc Natl Acad Sci U S A199996127088709210359843
   PubMed Web of Science ®Google Scholar
• BasergaRPeruzziFReissKThe IGF-1 receptor in cancer biologyInt J Cancer2003107687387714601044
   PubMed Web of Science ®Google Scholar
• BasergaRPorcuPRubiniMSellCCell cycle control by the IGF-1 receptor and its ligandsAdv Exp Med Biol19933431051128184731
   PubMedGoogle Scholar
• CosmanDLymanSDIdzerdaRLA new cytokine receptor superfamilyTrends Biochem Sci19901572652702166365
   PubMed Web of Science ®Google Scholar
• CruickshankJGrossmanDIPengRKFamulaTROberbauerAMSpatial distribution of growth hormone receptor, insulin-like growth factor-I receptor and apoptotic chondrocytes during growth plate developmentJ Endocrinol2005184354355315749813
   PubMed Web of Science ®Google Scholar
• SchwanderJCHauriCZapfJFroeschERSynthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone statusEndocrinology198311312973056190641
   PubMed Web of Science ®Google Scholar
• WernerHLeRoithDThe role of the insulin-like growth factor system in human cancerAdv Cancer Res1996681832238712068
   PubMed Web of Science ®Google Scholar
• HoKYVeldhuisJDJohnsonMLFasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in manJ Clin Invest19888149689753127426
   PubMed Web of Science ®Google Scholar
• GiustinaAScalviniTTassiCMaturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosteroneJ Clin Endocrinol Metab1997824121012199100598
   PubMed Web of Science ®Google Scholar
• KeenanBSRichardsGEPonderSWDallasJSNagamaniMSmithERAndrogen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed pubertyJ Clin Endocrinol Metab199376499610018473416
   PubMed Web of Science ®Google Scholar
• LocheSColaoACappaMThe growth hormone response to hexarelin in children: reproducibility and effect of sex steroidsJ Clin Endocrinol Metab19978238618649062497
   PubMed Web of Science ®Google Scholar
• KerriganJRRogolADThe impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescenceEndocr Rev19921322812981618164
   PubMed Web of Science ®Google Scholar
• JospeNOrlowskiCCFurlanettoRWComparison of transdermal and oral estrogen therapy in girls with Turner’s syndromeJ Pediatr Endocrinol Metab1995821111167584704
   PubMed Web of Science ®Google Scholar
• HarrisDAVan VlietGEgliCASomatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonistJ Clin Endocrinol Metab19856111521593889035
   PubMed Web of Science ®Google Scholar
• MansfieldMJRudlinCRCriglerJFJrChanges in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious pubertyJ Clin Endocrinol Metab1988661392961786
   PubMed Web of Science ®Google Scholar
• BlumWFAlbertsson-WiklandKRosbergSRankeMBSerum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretionJ Clin Endocrinol Metab1993766161016167684744
   PubMed Web of Science ®Google Scholar
• BrabantGvon zur MühlenAWüsterCSerum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter studyHorm Res2003602536012876414
   PubMedGoogle Scholar
• GiustiMTorreRCavagnaroPAttanasioRTraversoLGiordanoGThe effect of long-term pulsatile GnRH administration on the 24-hour integrated concentration of GH in hypogonadotropic hypogonadic patientsActa Endocrinol (Copenh)198912067247282499152
   PubMedGoogle Scholar
• WeissbergerAJHoKKActivation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatizationJ Clin Endocrinol Metab1993766140714128501143
   PubMed Web of Science ®Google Scholar
• BondanelliMAmbrosioMRMarguttiAFranceschettiPZatelliMCdegli UbertiECActivation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormoneNeuroendocrinology200377638038712845224
   PubMed Web of Science ®Google Scholar
• LiuLMerriamGRSherinsRJChronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadismJ Clin Endocrinol Metab19876446516563546349
   PubMed Web of Science ®Google Scholar
• VeldhuisJDKeenanDMMielkeKMilesJMBowersCYTestosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacyEur J Endocrinol2005153457758616189179
   PubMed Web of Science ®Google Scholar
• MaurasNRiniAWelchSSagerBMurphySPSynergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boysMetabolism200352896496912898459
   PubMed Web of Science ®Google Scholar
• SaggeseGCesarettiGFranchiGStartariLTestosterone-induced increase of insulin-like growth factor I levels depends upon normal levels of growth hormoneEur J Endocrinol199613522112158810735
   PubMed Web of Science ®Google Scholar
• GibneyJWolthersTJohannssonGUmplebyAMHoKKGrowth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary menAm J Physiol Endocrinol Metab20052892E266E27115727949
   PubMed Web of Science ®Google Scholar
• OvesenPVahlNFiskerSVeldhuisJDChristiansenJSJørgensenJOIncreased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal womenJ Clin Endocrinol Metab1998835166216679589674
   PubMed Web of Science ®Google Scholar
• WeissbergerAJHoKKLazarusLContrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal womenJ Clin Endocrinol Metab19917223743811991807
   PubMed Web of Science ®Google Scholar
• MollGWJrRosenfieldRLFangVSAdministration of low-dose estrogen rapidly and directly stimulates growth hormone productionAm J Dis Child198614021241273946321
   PubMedGoogle Scholar
• SchoberEFrischHWaldhauserFBieglmayrCInfluence of estrogen administration on growth hormone response to GHRH and L-Dopa in patients with Turner’s syndromeActa Endocrinol (Copenh)198912044424462497615
   PubMedGoogle Scholar
• LeungKCJohannssonGLeongGMHoKKEstrogen regulation of growth hormone actionEndocr Rev200425569372115466938
   PubMed Web of Science ®Google Scholar
• FriendKEHartmanMLPezzoliSSClaseyJLThornerMOBoth oral and transdermal estrogen increase growth hormone release in postmenopausal women – a clinical research center studyJ Clin Endocrinol Metab1996816225022568964860
   PubMed Web of Science ®Google Scholar
• GibneyJJohannssonGLeungKCHoKKComparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient womenJ Clin Endocrinol Metab20059073897390315855258
   PubMed Web of Science ®Google Scholar
• LiuPYHoeyKAMielkeKLVeldhuisJDKhoslaSA randomized placebo-controlled trial of short-term graded transdermal estradiol in healthy gonadotropin-releasing hormone agonist-suppressed pre- and postmenopausal women: effects on serum markers of bone turnover, insulin-like growth factor-I, and osteoclastogenic mediatorsJ Clin Endocrinol Metab20059041953196015623811
   PubMed Web of Science ®Google Scholar
• RothJGlickSMYalowRSBersonSASecretion of human growth hormone: physiologic and experimental modificationMetabolism19631257757913975314
   PubMed Web of Science ®Google Scholar
• ImakiTShibasakiTShizumeKThe effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in manJ Clin Endocrinol Metab19856022902933917457
   PubMed Web of Science ®Google Scholar
• MerimeeTJRabinowtitzDFinebergSEArginine-initiated release of human growth hormone. Factors modifying the response in normal manN Engl J Med196928026143414385786514
   PubMed Web of Science ®Google Scholar
• MelmedSInsulin suppresses growth hormone secretion by rat pituitary cellsJ Clin Invest1984735142514336371058
   PubMed Web of Science ®Google Scholar
• VahlNJørgensenJOSkjaerbaekCVeldhuisJDOrskovHChristiansenJSAbdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adultsAm J Physiol19972726 Pt 1E1108E11169227458
   PubMedGoogle Scholar
• ButlerAALe RoithDControl of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent rolesAnnu Rev Physiol20016314116411181952
   PubMed Web of Science ®Google Scholar
• PhilippouAHalapasAMaridakiMKoutsilierisMType I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophyJ Musculoskelet Neuronal Interact20077320821817947802
   PubMedGoogle Scholar
• NyombaBLBerardLMurphyLJFree insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivityJ Clin Endocrinol Metab1997827217721819215291
   PubMed Web of Science ®Google Scholar
• BerelowitzMSzaboMFrohmanLAFirestoneSChuLHintzRLSomatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitaryScience19812124500127912816262917
   PubMed Web of Science ®Google Scholar
• BertheratJBluet-PajotMTEpelbaumJNeuroendocrine regulation of growth hormoneEur J Endocrinol1995132112247850005
   PubMed Web of Science ®Google Scholar
• BonefeldKMøllerSInsulin-like growth factor-I and the liverLiver Int201131791191921733081
   PubMed Web of Science ®Google Scholar
• BuzzelliGDattoloPPinzaniMBrocchiARomanoSGentiliniPCirculating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythmAm J Gastroenterol19938810174417488213718
   PubMed Web of Science ®Google Scholar
• DaughadayWHRotweinPInsulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrationsEndocr Rev198910168912666112
   PubMed Web of Science ®Google Scholar
• HollyJMWassJAInsulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developmentsJ Endocrinol198912236116182478648
   PubMed Web of Science ®Google Scholar
• TannenbaumGSGuydaHJPosnerBIInsulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brainScience1983220459277796338593
   PubMed Web of Science ®Google Scholar
• UnderwoodLED’ErcoleAJClemmonsDRVan WykJJParacrine functions of somatomedinsClin Endocrinol Metab198615159773514004
   PubMedGoogle Scholar
• MuggeoMTiengoAFedeleDCrepaldiGAltered control of growth hormone secretion in patients with cirrhosis of the liverArch Intern Med19791391011571160485748
   PubMedGoogle Scholar
• SchimpffRMLebrecDDonnadieuMSomatomedin production in normal adults and cirrhotic patientsActa Endocrinol (Copenh)1977862355362578625
   PubMedGoogle Scholar
• ChangTCLinJJYuSCChangTJAbsence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liverHepatology19901111231262153093
   PubMed Web of Science ®Google Scholar
• StratikopoulosESzabolcsMDragatsisIKlinakisAEfstratiadisAThe hormonal action of IGF1 in postnatal mouse growthProc Natl Acad Sci U S A200810549193781938319033454
   PubMed Web of Science ®Google Scholar
• KupferSRUnderwoodLEBaxterRCClemmonsDREnhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneouslyJ Clin Invest19939123913967679407
   PubMed Web of Science ®Google Scholar
• ClemmonsDRMetabolic actions of insulin-like growth factor-I in normal physiology and diabetesEndocrinol Metab Clin North Am2012412425443viiviii22682639
   PubMed Web of Science ®Google Scholar
• RenehanAGBrennanBMAcromegaly, growth hormone and cancer riskBest Pract Res Clin Endocrinol Metab200822463965718971124
   PubMed Web of Science ®Google Scholar
• BougenNMSteinerMPertzigerMAutocrine human GH promotes radioresistance in mammary and endometrial carcinoma cellsEndocr Relat Cancer201219562564422807498
   PubMed Web of Science ®Google Scholar
• BougenNMYangTChenHLobiePEPerryJKAutocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin COncol Rep201126248749321567106
   PubMed Web of Science ®Google Scholar
• MazzoccoliGSothernRBPazienzaVCircadian aspects of growth hormone-insulin-like growth factor axis function in patients with lung cancerClin Lung Cancer2012131687421729653
   PubMed Web of Science ®Google Scholar
• MinoiaMGentilinEMolèDGrowth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expressionJ Clin Endocrinol Metab2012976E907E91622442272
   PubMed Web of Science ®Google Scholar
• PerryJKEmeraldBSMertaniHCLobiePEThe oncogenic potential of growth hormoneGrowth Horm IGF Res2006165–627728917101287
   PubMed Web of Science ®Google Scholar
• WuZSYangKWanYTumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinomaJ Clin Endocrinol Metab20119610E1619E162921849525
   PubMed Web of Science ®Google Scholar
• ZatelliMCMinoiaMMolèDGrowth hormone excess promotes breast cancer chemoresistanceJ Clin Endocrinol Metab200994103931393819622619
   PubMed Web of Science ®Google Scholar
• WernerHWeinsteinDBentovISimilarities and differences between insulin and IGF-I: structures, receptors, and signalling pathwaysArch Physiol Bochem200811411722
   PubMedGoogle Scholar
• LeeYHWhiteMFInsulin receptor substrate proteins and diabetesArch Pharm Res200427436137015180298
   PubMed Web of Science ®Google Scholar
• ClemmonsDMaileLXiGShenXRadhakrishnanYIgf-I signaling in response to hyperglycemia and the development of diabetic complicationsCurr Diabetes Rev20117423524521707534
   PubMedGoogle Scholar
• ChambersAFGroomACMacDonaldICDissemination and growth of cancer cells in metastatic sitesNat Rev Cancer20022856357212154349
   PubMed Web of Science ®Google Scholar
• FeldserDAganiFIyerNVPakBFerreiraGSemenzaGLReciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2Cancer Res199959163915391810463582
   PubMed Web of Science ®Google Scholar
• ZelzerELevyYKahanaCShiloBZRubinsteinMCohenBInsulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNTEMBO J19981717508550949724644
   PubMed Web of Science ®Google Scholar
• FukudaRHirotaKFanFJungYDEllisLMSemenzaGLInsulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cellsJ Biol Chem2002277413820538201112149254
   PubMed Web of Science ®Google Scholar
• ClarkeKSmithKGullickWJHarrisALMutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathwayBr J Cancer200184101322132911355942
   PubMed Web of Science ®Google Scholar
• ShigematsuSYamauchiKNakajimaKIijimaSAizawaTHashizumeKIGF-1 regulates migration and angiogenesis of human endothelial cellsEndocr J199946SupplS59S6212054122
   PubMedGoogle Scholar
• LeeOHBaeSKBaeMHIdentification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis modelsBr J Cancer200082238539110646893
   PubMed Web of Science ®Google Scholar
• Grulich-HennJRitterJMesewinkelSHeinrichUBettendorfMPreissnerKTTransport of insulin-like growth factor-I across endothelial cell monolayers and its binding to the subendothelial matrixExp Clin Endocrinol Diabetes20021102677311928068
   PubMed Web of Science ®Google Scholar
• MiraEMañesSLacalleRAMárquezGMartínezACInsulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9Endocrinology199914041657166410098500
   PubMed Web of Science ®Google Scholar
• DunnSETorresJVNiheiNBarrettJCThe insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapyMol Carcinog2000271101710642432
   PubMed Web of Science ®Google Scholar
• SmithBWAdamsLANon-alcoholic fatty liver diseaseCrit Rev Clin Lab Sci20114839711321875310
   PubMed Web of Science ®Google Scholar
• CuneoRCHickmanPEWallaceJDAltered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver diseaseClin Endocrinol (Oxf)19954332652757586594
   PubMed Web of Science ®Google Scholar
• SkrticSWalleniusKGressnerAMJanssonJOInsulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor productionEndocrinology1999140125729573510579338
   PubMed Web of Science ®Google Scholar
• SkrticSWalleniusVEkbergSBrenzelAGressnerAMJanssonJOInsulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cellsEndocrinology199713811468346899348194
   PubMed Web of Science ®Google Scholar
• MatsudaYMatsumotoKYamadaAPreventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosisHepatology199726181899214455
   PubMed Web of Science ®Google Scholar
• PucheJECastilla- CortázarIHuman conditions of insulin-like growth factor-I (IGF-I) deficiencyJ Transl Med20121022423148873
   PubMed Web of Science ®Google Scholar
• ArturiFSuccurroEProcopioCNonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-IJ Clin Endocrinol Metab20119610E1640E164421816784
   PubMed Web of Science ®Google Scholar
• VölzkeHNauckMRettigRAssociation between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sampleEur J Endocrinol2009161570571319690083
   PubMed Web of Science ®Google Scholar
• AnthonyPPIshakKGNayakNCPoulsenHEScheuerPJSobinLHThe morphology of cirrhosis: definition, nomenclature, and classificationBull World Health Organ1977554521540304393
   PubMed Web of Science ®Google Scholar
• AssyNHochbergZEnatRBaruchYPrognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosisDig Dis Sci1998436131713219635625
   PubMed Web of Science ®Google Scholar
• AssyNPruzanskyYGaitiniDShen OrrZHochbergZBaruchYGrowth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunctionJ Hepatol2008491344218456366
   PubMed Web of Science ®Google Scholar
• CaregaroLAlberinoFAmodioPNutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosisNutrition19971331851909131676
   PubMed Web of Science ®Google Scholar
• CastroGRCoelhoJCParolinMBMatiasJEde FreitasACInsulin-like growth factor I correlates with MELD and returns to normal level after liver transplantationAnn Transplant201318576223792502
   PubMed Web of Science ®Google Scholar
• DehghaniSMKaramifarHHamzaviSSHaghighatMMalek-HosseiniSASerum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplantExp Clin Transplant201210325225722631062
   PubMed Web of Science ®Google Scholar
• DonaghyAJDelhantyPJHoKKWilliamsRBaxterRCRegulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosisJ Hepatol200236675175812044524
   PubMed Web of Science ®Google Scholar
• ElsammakMYAminGMKhalilGMRagabWSAbazaMMPossible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasisClin Biochem200639662362916624274
   PubMed Web of Science ®Google Scholar
• JeyaratnaganthanNGrønbaekHHolland-FischerPAscites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serumClin Endocrinol (Oxf)201072562563219769623
   PubMed Web of Science ®Google Scholar
• Lorenzo-ZúñigaVBartolíRMasnouHMontoliuSMorillasRMPlanasRSerum concentrations of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis CDig Dis Sci200752113245325017410466
   PubMed Web of Science ®Google Scholar
• MazziottiGSorvilloFMoriscoFSerum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective studyCancer200295122539254512467068
   PubMed Web of Science ®Google Scholar
• MøllerSGrønbaekMMainKBeckerUSkakkebaekNEUrinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosisJ Hepatol19931733153208315259
   PubMed Web of Science ®Google Scholar
• RehemRNEl-ShikhWMSerum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinomaHepatogastroenterology201158107–10894995421830422
   PubMedGoogle Scholar
• RonsoniMFLazzarottoCFayadLIGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosisAnn Hepatol201312345646323619263
   PubMed Web of Science ®Google Scholar
• SandahlTDAagaardNKThomsenKLEffects of insulin-like growth factor-I administration on in vivo regulation of urea synthesis in normal subjects and patients with cirrhosisLiver Int201131113213721040412
   PubMed Web of Science ®Google Scholar
• VyzantiadisTTheodoridouSGioulemeOHarsoulisPEvgenidisNVyzantiadisASerum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosisHepatogastroenterology2003505181481612828091
   PubMedGoogle Scholar
• WuYLYeJZhangSZhongJXiRPClinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosisWorld J Gastroenterol200410182740274315309731
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253419095497
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSHARP Investigators Study GroupSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• LlovetJMDi BisceglieAMBruixJPanel of Experts in HCC-Design Clinical TrialsDesign and endpoints of clinical trials in hepatocellular carcinomaJ Natl Cancer Inst20081001069871118477802
   PubMedGoogle Scholar
• WilsonSRGreigPKasebAOPretreatment assessment of hepatocellular cancer: expert consensus conferenceHPB (Oxford)201012530030120590902
   PubMed Web of Science ®Google Scholar
• ChevretSTrinchetJCMathieuDRachedAABeaugrandMChastangCA new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d’Etude et de Traitement du Carcinome HepatocellulaireJ Hepatol199931113314110424293
   PubMed Web of Science ®Google Scholar
• KudoMChungHOsakiYPrognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)J Gastroenterol200338320721512673442
   PubMed Web of Science ®Google Scholar
• LeungTWTangAMZeeBConstruction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patientsCancer20029461760176911920539
   PubMed Web of Science ®Google Scholar
• LlovetJMBrúCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis199919332933810518312
   PubMed Web of Science ®Google Scholar
• OkudaKOhtsukiTObataHNatural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patientsCancer19855649189282990661
   PubMed Web of Science ®Google Scholar
• PonsFVarelaMLlovetJMStaging systems in hepatocellular carcinomaHPB (Oxford)200571354118333159
   PubMedGoogle Scholar
• TateishiRYoshidaHShiinaSProposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patientsGut200554341942515710994
   PubMed Web of Science ®Google Scholar
• No authors listedA new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigatorsHepatology19982837517559731568
   PubMed Web of Science ®Google Scholar
• JørgensenJOBlumWFMøllerNRankeMBChristiansenJSCircadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age- and sex-matched normal subjectsActa Endocrinol (Copenh)199012332572621700568
   PubMedGoogle Scholar
• National Comprehensive Cancer Network clinical practice guidelines: Hepatobiliary Cancers http://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf2015 version 2Accessed July 24, 2015
   Google Scholar
• ThomasMBJaffeDChotiMMHepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingJ Clin Oncol201028253994400520679622
   PubMed Web of Science ®Google Scholar
• VerslypeCRosmorducORougierPESMO Guidelines Working GroupHepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol2012237vii414822997453
   PubMed Web of Science ®Google Scholar
• KasebAOAbbruzzeseJLVautheyJNI-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP scoreOncology2011805–637338121822028
   PubMed Web of Science ®Google Scholar
• KasebAOMorrisJSHassanMMClinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinomaJ Clin Oncol201129293892389921911725
   PubMed Web of Science ®Google Scholar
• StuverSOKuperHTzonouAInsulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in menInt J Cancer200087111812110861461
   PubMed Web of Science ®Google Scholar
• SuWWLeeKTYehYTAssociation of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation studyJ Clin Lab Anal201024319520020486202
   PubMed Web of Science ®Google Scholar
• AssyNHochbergZAmitTShen-OrrZEnatRBaruchYGrowth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosisJ Hepatol19972757968029382965
   PubMed Web of Science ®Google Scholar
• De BenedettiFAlonziTMorettaAInterleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammationJ Clin Invest19979946436509045866
   PubMed Web of Science ®Google Scholar
• JonesJIClemmonsDRInsulin-like growth factors and their binding proteins: biological actionsEndocr Rev19951613347758431
   PubMed Web of Science ®Google Scholar
• KasebAOXiaoLHassanMMDevelopment and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinomaJ Natl Cancer Inst20141065
   Google Scholar
• ElmashadNIbrahimWSMayahWWPredictive value of serum insulin-like growth factor-1 in hepatocellular carcinomaAsian Pac J Cancer Prev201516261361925684496
   PubMedGoogle Scholar
• ChoEKimHCLeeJHSerum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolizationPLoS One201493e9086224595361
   PubMed Web of Science ®Google Scholar
• BruixJShermanMPractice Guidelines Committee, American Association for the Study of Liver DiseasesManagement of hepatocellular carcinomaHepatology20054251208123616250051
   PubMed Web of Science ®Google Scholar